Neoadjuvant PD-1 Blockade in Patients with Stage IIB/C Melanoma

NCT03757689 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

63

Enrollment

OTHER

Sponsor class

Conditions

Melanoma

Interventions

DRUG: Pembrolizumab
PROCEDURE: Wide Excision and Sentinel Lymph Node (SLN) Biopsy

Sponsor

Abramson Cancer Center at Penn Medicine